Ovarian Cancer Vaccine for Patients in Remission
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angeles Secord, MD
Duke University
Principal Investigator - Benedict Benigno, MD
Northside Hospital
Principal Investigator - Fernando Recio, MD
Collaborative Research Group
Principal Investigator - Giuseppe Del Priore, MD
Indiana University
Principal Investigator - Heidi Gray, MD
University of Washington
Principal Investigator - James Mason, MD
Scripps Cancer Center
Principal Investigator - Jeffrey Goh, MBBS, FRACP
Greenslopes Private Hospital
Principal Investigator - Jennifer Young, MD
Medical University of South Carolina
Principal Investigator - Jonathan Berek, MD, MMS
Stanford University
Principal Investigator - Linda Mileshkin, MBBS
Peter MacCallum Cancer Centre, Australia
Principal Investigator - Marco Matos, FRACP
Gold Coast Hospital
Principal Investigator - Margaret Davy, MBBS, CGO
Royal Adelaide Hospital
Principal Investigator - Mark Moradi, MD
New York Presbyterian Hospital
Principal Investigator - Nana Tchabo, MD
Morristown Medical Center
Principal Investigator - Paul Mitchell, MB ChB
Austin Health Cancer Care
Principal Investigator - Peter Eisenberg, MD
Marin Cancer Care
Principal Investigator - Peter Rose, MD
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Greenslopes Private Hospital
Greenslopes, Queensland, Australia
- Gold Coast Hospital
Southport, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Peter Maccallum Cancer Cetnre
East Melbourne, Victoria, Australia
- Austin Health Cancer Centre
Heidelberg, Victoria, Australia
- Marin Cancer Care, Inc.
Greenbrae, California, United States
- Scripps Cancer Center
La Jolla, California, United States
- Stanford University School of Medicine
Palo Alto, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Collaborative Research Group
Boca Raton, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Morristown Medical Center
Morristown, New Jersey, United States
- New York Downtown Hospital
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2010
- Primary completion
- 31 Aug 2013
- Completion
- 30 Apr 2015
- Last update posted
- 11 May 2017
- Registered enrollment
- 63
- Registry id
- NCT01068509
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.